IP Library Granted Patent US 12,560,598
Granted Patent B2
US 12,560,598 · App. 17/683,694 · Granted Feb 24, 2026

Cartridge-based automated rapid test analyzer

Inventor: Newton Howard (Washington, DC)
Assignee: Genesis Intelligence, LLC
G01N33/54333G01N15/06G01N33/533G01N15/01G01N2015/0681G01N2015/0687G01N15/075G01N2333/165G01N2469/10G01N2469/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,560,598
App. No.
17/683,694
Granted
Feb 24, 2026
Kind
B2
Abstract

Embodiments may include a rapid test device that provide rapid detection of substances, including those involved in pathogen infection, for example, using Microscale Affinity Chromatography (MAC), indirect ELISA, and optical molecular sensing technology. For example, in an embodiment, an apparatus may comprise a loading bay disposed on the apparatus to receive a cartridge, a door disposed on the apparatus to cover the loading bay, a plurality of prongs disposed on an interior of the door to provide actuation force to dispense blister reservoirs disposed on the cartridge when the door is closed, and a device disposed relative to the cartridge to move at least a portion of contents of the cartridge among chambers of the cartridge.

Claims (27)

1 . An apparatus comprising:

a loading bay disposed on the apparatus to receive a cartridge comprising a plurality of blister reservoirs;

a door disposed on the apparatus to cover the loading bay;

a plurality of blunt prongs disposed on an interior of the door to provide actuation force to the plurality of hermetically sealed blister reservoirs disposed on the cartridge when the door is closed, to directly depress each of the plurality of blister reservoirs so as dispense contents of the plurality of blister reservoirs into chambers of the cartridge associated with each blister reservoir; and

a device disposed relative to the cartridge to move at least a portion of contents of the cartridge among chambers of the cartridge, including chambers of the cartridge associated with each blister reservoir.

2 . The apparatus of claim 1 , wherein the device disposed relative to the cartridge to move at least a portion of the contents of the cartridge among chambers of the cartridge comprises:

a motor having disposed on a drive shaft thereof a pinion;

a rack meshed with the pinion; and

a magnetic device disposed on the pinion and disposed relative to the cartridge so as to move at least a portion of the contents of the cartridge among chambers of the cartridge when the motor is driven.

3 . The apparatus of claim 2 , wherein the magnetic device comprises a permanent magnet or a magnetic coil.

4 . The apparatus of claim 3 , wherein a portion of the contents of the cartridge comprises magnetic beads.

5 . The apparatus of claim 2 , wherein the apparatus further comprises a computer system comprising a processor, memory to store program instructions and data and accessible by the processor, and program instructions stored in the memory and executable by the processor to control driving of the motor.

6 . The apparatus of claim 5 , wherein the cartridge comprises:

a first chamber configured to receive a test sample including a target substance, the first chamber pre-filled with micromagnetic particles treated so as to bind to the target substance; and

a first reservoir pre-filled with reagent labeled with a fluorescent compound, the reagent adapted to bind to treated micromagnetic particles that are bound to the target substance.

7 . The apparatus of claim 6 , wherein the program instructions comprise program instructions to cause the computer system to drive the motor so as to:

mix the treated micromagnetic particles with the test sample by moving the micromagnetic particles, so as to facilitate binding of the treated micromagnetic particles to the target substance; and

mix the treated micromagnetic particles with the reagent labeled with a fluorescent compound, so as to facilitate binding to the treated micromagnetic particles bound to the target substance.

8 . The apparatus of claim 7 , wherein the cartridge further comprises a detection region.

9 . The apparatus of claim 8 , wherein the program instructions further comprise program instructions to cause the computer system to drive the motor so as to:

move the micromagnetic particles to the detection region after the reagent labeled with a fluorescent compound have bound to the treated micromagnetic particles bound to the target substance.

10 . The apparatus of claim 9 , further comprising circuitry configured to detect fluorescence of the fluorescent compound disposed relative to the detection region of the cartridge.

11 . The apparatus of claim 10 , wherein the circuitry configured to detect fluorescence of the fluorescent compound comprises:

at least one excitation light emitting diode arranged to illuminate the detection region so as to excite fluorescence of the fluorescent compound; and

at least one photodiode arranged to detect the excited fluorescence of the fluorescent compound in the detection region and to output a signal representing the detected fluorescence.

12 . The apparatus of claim 11 , wherein the processor is configured to receive the signal representing the detected fluorescence and the program instructions stored in the memory further include program instructions configured to determine presence of the target substance based on the received signal.

13 . The apparatus of claim 12 , further comprising a display configured to display presence of the target substance, wherein the display is connected to the processor, and the program instructions stored in the memory further include program instructions configured to control the display based on the determined presence of the target substance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2025
From: HOWARD, NEWTON
To: GENESIS INTELLIGENCE, LLC
Reel/Frame 073374/0001 →
Continuity (9)
Continuation In Part 16855709 · Apr 22, 2020
Provisional Application 63280783 · Nov 18, 2021
Provisional Application 63163027 · Mar 18, 2021
Provisional Application 63001291 · Mar 28, 2020
Provisional Application 62994165 · Mar 24, 2020
Provisional Application 62993222 · Mar 23, 2020
Provisional Application 62991906 · Mar 19, 2020
Provisional Application 62988320 · Mar 11, 2020
Related Publication 20220178920A1 · Jun 9, 2022
References Cited (103)
US 5238810A · Fujiwara · 1993 [cited by applicant]
US 6500671B2 · Hage · 2002 [cited by applicant]
US 6649128B1 · Meyer · 2003 [cited by examiner]
US 6727104B2 · Hage · 2004 [cited by applicant]
US 6884357B2 · Siddiqi · 2005 [cited by applicant]
US 7575908B1 · Hage · 2009 [cited by applicant]
US 8268570B2 · Hage · 2012 [cited by applicant]
US 10154812B2 · Howard · 2018 [cited by applicant]
US 10822379B1 · Dimitrov · 2020 [cited by applicant]
US 20020031839A1 · Mcneirney · 2002 [cited by applicant]
US 20020151086A1 · Hage · 2002 [cited by applicant]
US 20030219713A1 · Valencia · 2003 [cited by applicant]
US 20060134713A1 · Rylatt · 2006 [cited by examiner]
US 20060148096A1 · Jina · 2006 [cited by examiner]
US 20070187251A1 · Ward · 2007 [cited by applicant]
US 20080160277A1 · Tamori · 2008 [cited by applicant]
US 20090042237A1 · Smith · 2009 [cited by applicant]
US 20090297546A1 · Yamada · 2009 [cited by applicant]
US 20100248258A1 · Lee · 2010 [cited by examiner]
US 20100261203A1 · Cicciarelli · 2010 [cited by applicant]
US 20100291561A1 · Milligan · 2010 [cited by applicant]
US 20110104163A1 · Dimitrov · 2011 [cited by applicant]
US 20120100152A1 · Roberts · 2012 [cited by applicant]
US 20130078620A1 · Gandini · 2013 [cited by applicant]
US 20130157892A1 · Grunert · 2013 [cited by applicant]
US 20130273524A1 · Ehrenkranz · 2013 [cited by applicant]
US 20150038347A1 · Johnson · 2015 [cited by applicant]
US 20150132776A1 · Kasdan · 2015 [cited by applicant]
US 20150293093A1 · Charles · 2015 [cited by applicant]
US 20150368327A1 · Goshima · 2015 [cited by applicant]
US 20170284922A1 · Mermod · 2017 [cited by examiner]
US 20180289318A1 · Howard · 2018 [cited by applicant]
US 20190025323A1 · Higel · 2019 [cited by applicant]
US 20190032114A1 · Trivedi · 2019 [cited by applicant]
US 20190344269A1 · Johnson · 2019 [cited by applicant]
US 20200237299A1 · Howard · 2020 [cited by applicant]
US 20200290038A1 · Falconnet · 2020 [cited by applicant]
US 20210180110A1 · Shachar · 2021 [cited by applicant]
US 20210291177A1 · Rothberg · 2021 [cited by examiner]
US 20210311073A1 · Lapointe · 2021 [cited by applicant]
WO 1999035486A1 · 1999 [cited by applicant]
WO 2006138561A1 · 2006 [cited by applicant]
WO 2011156713A1 · 2011 [cited by applicant]
WO 2015150742A1 · 2015 [cited by applicant]
Anderson, RM and May, RM. “Vaccination and herd immunity to infectious diseases.” Journal Article. (Nov. 1985) 324-329. vol. 318. Issue 6044. Nature. [cited by applicant]
Beeram, S.R., Zheng, X., Suh, K., Hage, D.S. “Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.” Journal Article. (Aug. 2018) 46-57. vol. 146. Methods. [cited by applicant]
Chen, L., Xiong, J., Bao, L., & Shi, Y.“Convalescent plasma as a potential therapy for covid-19.” Journal Article. (Feb. 2020) 398-400. vol. 20. Issue 4. The Lancet Infectious Diseases. [cited by applicant]
Clarke, W., Schiel, J.E., Moser, A., Hage, D. “Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: Studies using free thyroxine as a model system.” Journal Article. (Feb. 2005) … [cited by applicant]
Constantine, N., (May 2006). “HIV InSite Knowledge Base Chapter.” Website. Retrieved from http://hivinsite.ucsf.edu/InSite?page=kb-02-02-01. [cited by applicant]
“Coronavirus (COVID-19) IgM/IgG Rapid Test Kit.” (2020) Website. Retrieved from https://www.raybiotech.com/covid-19-igm-igg-rapid-test-kit/. [cited by applicant]
Kelvin Kai-Wang To, Owen Tak-Yin Tsang, Cyril Chik-Yan Yip, Kwok-Hung Chan, Tak-Chiu Wu, Jacky Man-Chun Chan, Wai-Shing Leung, Thomas Shiu-Hong Chik, Chris Yau-Chung Choi, Darshana H Kandamby, David Christopher Lung, An… [cited by applicant]
Daaboul, G. G., Freedman, D. S., Scherr, S. M., Carter, E., Rosca, A., Bernstein, D., Mire, C. E., Agans, K. N., Hoenen, T., Geisbert, T. W., Ünlü, M. S., & Connor, J. H. “Enhanced light microscopy visualization of viru… [cited by applicant]
Dawood, F.S, Chung, J.R, Kim, S.S, Zimmerman, R.K, Nowalk, M.P, Jackson, M.L, Jackson, L.A, Monto, A.S, Martin, E.T, Belongia, E.A, Mclean, H.Q, Gaglani, M., Dunnigan, K., Foust, A., Sessions, W., Dasilva, J., Le S.,, a… [cited by applicant]
Díaz, R., Casanova, A., Ariza,J., Moriyón, I. “The rose bengal test in human brucellosis: A neglected test for the diagnosis of a neglected disease.” Journal Article. (Apr. 2011) e950. vol. 5. Issue 4. PLoS Negl Trop Di… [cited by applicant]
El-Tholoth, Mohamed; Bau, Haim H.; Song, Jinzhao. “A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry.” Journal Article. (Feb. 2020) ChemRx… [cited by applicant]
Fehr, Anthony R, and Stanley Perlman. “Coronaviruses: an overview of their replication and pathogenesis.” Journal Article. vol. 1282 (Feb. 2015): 1-23. Methods in molecular biology (Clifton, N.J.). [cited by applicant]
Fu, L., Leong, J., Lin, C. et al. “High performance microfluidic capillary electrophoresis devices.” Journal Article. (May 2007) 405-412. vol. 9. Biomed microdevices. [cited by applicant]
Genetex. “SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9].” Website. (Mar. 2020) Retrieved from https://www.genetex.com/Product/Detail/SARS-CoV-SARS-CoV-2-COVID-19-spike-antibody-1A9/GTX632604. [cited by applicant]
Nabila A. Ghazy, Wafaa R. Abdel Aziz, Waleed S. Shell and A.A. Samy. “Efficiency of different preparations of rapid slide agglutination antigens for the diagnosis of bovine and ovine brucellosis.” Journal Article. (2016… [cited by applicant]
Hage, D.S. “Survey of recent advances in analytical applications of immunoaffinity chromatography.” Journal Article. (Sep. 1998) 3-28. 715. 1. Journal of Chromatography B: Biomedical Sciences and Applications. [cited by applicant]
Hage, DS (ed.) “Handbook of affinity chromatography.” Book. (2006) Taylor & Francis. Boca Raton. [cited by applicant]
Hettegger, P., Huber, J., Passecke, K., Soldo, R., Kegler, U., Nöhammer, C., & Weinhäusel, A. “High similarity of igG antibody profiles in blood and saliva opens opportunities for saliva based serology.” Journal Article… [cited by applicant]
Hodinka, R.L., Nagashunmugam, T., Malamud, D. “Detection of human immunodeficiency virus antibodies in oral fluids. Clinical and diagnostic laboratory immunology.” Journal Article. (Jul. 1998) 419-426. vol. 5. Issue 4. … [cited by applicant]
Colmenero, J. D. Ruiz-Mesa J. Sánchez-Gonzalez J. M. Reguera L. Martín S. Lopez-Palmero J. D. “Rose bengal test: Diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic … [cited by applicant]
Johns Hopkins Center for Health Security. “Sars-CoV-2 genetics.” White Paper (Apr. 2020) Retrieved from: https://www.centerforhealthsecurity.org/resources/COVID-19/COVID-19-fact-sheets/200128-nCoV-whitepaper.pdf. [cited by applicant]
Lee, J.E., Seo, J.H., Kim, C.S. et al. “A comparative study on antibody immobilization strategies onto solid surface.” Journal Article. (Aug. 2013) 1934-1938. vol. 30. Korean J. Chem. Eng. [cited by applicant]
Life Technologies. “Real-time PCR Handbook.” (2012) White Paper Retrieved from: https://www.gene-quantification.de/real-time-pcr-handbook-life-technologies-update-flr.pdf. [cited by applicant]
Lin A.V. “Indirect ELISA.” Book Chapter In: Hnasko R. (eds) “ELISA. Methods in Molecular Biology.” (2015) 51-59. vol. 1318. Humana Press, New York, NY. [cited by applicant]
Li, Z, Yi, Y, Luo, X, et al. “Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.” Journal Article. (Feb. 2020). 1-7. J Med Virol. [cited by applicant]
Lyons AB and Ashman LK. “The rose bengal assay for monoclonal antibodies to cell surface antigens: Comparisons with common hybridoma screening methods.” Journal Article. (1985) 325-345. 6. 4. J Immunoassay. (https://www… [cited by applicant]
James B. Mahony, Gord Blackhouse, Jesse Babwah, Marek Smieja, Sonya Buracond, Sylvia Chong, William Ciccotelli, Tim O'Shea, Daifallah Alnakhli, May Griffiths-Turner, Ron Goeree. “Cost analysis of multiplex pcr testing f… [cited by applicant]
Matsuda, R., Rodriguez, E., Suresh, D., Hage, D. “Chromatographic immunoassays: Strategies and recent developments in the analysis of drugs and biological agents.” Journal Article. (Nov. 2015) 2947-2966. 7. 22. Bioanaly… [cited by applicant]
Hage, DS and Moser, AC. “Immunoaffinity chromatography: An introduction to applications and recent developments.” Journal Article. (Apr. 2010) 2. 4. Bioanalysis. [cited by applicant]
National Center for Immunization and Respiratory Diseases (NCIRD). “How COVID-19 Spreads.” Website (Apr. 2020) Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html?CDC_AA… [cited by applicant]
Corey M. Ohnmacht, John E. Schiel, and David S. Hage. “Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay.” Journal Article. (Nov. 2006) 7547-7556… [cited by applicant]
O'Neill, H.C. and Parish, C.R. “A rapid automatic colorimetric assay for measuring antibody binding to cell surface antigens.” Journal Article. (1983) 257-286. vol. 64. Issue 3. Elsevier. (https://sci-hub.tw/https://doi… [cited by applicant]
Erika L. Pfaunmiller, Jeanethe A.Anguizola ,Mitchell L Milanuk, Natasha Carter, D.S.Hage, “Use of protein G microcolumns in chromatographic immunoassays: A comparison of competitive binding formats.” Journal Article. (M… [cited by applicant]
PubChem. “Fluorescein.” Website. (Mar. 2005) Retrieved from: https://pubchem.ncbi.nlm.nih.gov/compound/16850#section=Structures. [cited by applicant]
Rakesh, N.; Shetty, Shakilla; Sujatha, S.; Sharma, Shivani; Saxena, Ankit. “Assessment of the accuracy of whole blood/serum rapid point-of-care HIV three dot test for oral fluid specimens.” Journal Article. (2016) 354-3… [cited by applicant]
Cristiano Salata, Arianna Calistri, Cristina Parolin, Giorgio Palù. “Coronaviruses: A paradigm of new emerging zoonotic diseases.” Journal Article. (Dec. 2019) 77. 9. Pathogens and Disease. [cited by applicant]
Schoeman, D., Fielding, B.C. “Coronavirus envelope protein: Current knowledge.” Journal Article. (May 2019) 16. 69. Virol J. [cited by applicant]
Schramm, W., Angulo, G.B., Torres, P.C., Cassler, A.B., . “A simple saliva-based test for detecting antibodies to human immunodeficiency virus.” Journal Article. (Jul. 1999) 577-580. 6. 4. Clinical and Diagnostic Labora… [cited by applicant]
Servat, A., Feyssaguet, M., Blanchard, I,. Morize,J.L., Schereffer, J. L., Boue, F., Cliquet, F. “A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores.” Journa… [cited by applicant]
National Center for Immunization and Respiratory Diseases. (NCIRD), Division of Viral Diseases. (Feb. 2020) “Information for Laboratories.” Website. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-d… [cited by applicant]
The Native Antigen Company. (Feb. 2020) “Novel Coronavirus Antigens Now Available.” Website. Retrieved from: https://thenativeantigencompany.com/novel-coronavirus-antigens-now-available. [cited by applicant]
Tsekenis, G., Chatzipetrou, M., Massaouti, M., Zergioti, I. “Comparative assessment of affinity-based techniques for oriented antibody immobilization towards immunosensor performance optimization.” Journal Article. (Feb… [cited by applicant]
World Health Organization. (Mar. 2020). “WHO Director—General's Opening remarks at the media briefing on COVID-19.” Website. Retrieved from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-… [cited by applicant]
World Health Organization. (Mar. 2020) “Q&A on coronavirus (COVID-19)” Website. Retrieved From :https://www.who.int/news-room/q-a-detail/q-a-coronaviruses. [cited by applicant]
Chenhua Zhang, Ashley G.Woolfork, Kyungah Suh, Susan Ovbude, Cong Bi, Marawan Elzoeiry, David S.Hage. “Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: A review.” Journal Articl… [cited by applicant]
Xiwei Zheng, Zhao Li, Sandya Beeram, Maria Podariu, Ryan Matsuda, Erika L. Pfaunmiller, Christopher J. White, II, Natasha Carter, and David S. Hage. “Analysis of biomolecular interactions using affinity microcolumns: A … [cited by applicant]
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Al, Q., Lu, W., Liang, H., Li, S., & He, J. . “Cancer patients in SARS-CoV-2 infection: A nationwide analysis in china.” Journal Article. (Mar. 2020) 335-… [cited by applicant]
Xia Y, Jin R, Zhao J, Li W, Shen H. “Risk of covid-19 for patients with cancer.” Journal Article. (Apr. 2020) e180. 21. 4. Lancet Oncol. [cited by applicant]
Yu, J., Ouyang, W., Chua, M., & Xie, C. . “Sars-cov-2 transmission in patients with cancer at a tertiary care hospital in wuhan, china.” Advance online publication. (Mar. 2020) e200980. JAMA Oncol. [cited by applicant]
Smith, Chris. “Iceland's early coronavirus testing model shows 50% of cases have no symptoms.” Website. (Apr. 2020). BGR. Retrieved from: https://bgr.com/2020/04/05/coronavirus-testing-asymptomatic-covid-19-patients-can… [cited by applicant]
Center for Biologics Evaluation, & Research. (Apr. 2020). “Investigational COVID-19 Convalescent Plasma—Emergency INDs.” Retrieved from: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-devic… [cited by applicant]
Do, J., & Ahn, C. H. “A polymer lab-on-a-chip for magnetic immunoassay with on-chip sampling and detection capabilities.” Journal Article. (Feb. 2008) 542-549. 8. Lab Chip. [cited by applicant]
Li Guo, Lili Ren, Siyuan Yang, Meng Xiao, De Chang, Fan Yang, Charles S Dela Cruz, Yingying Wang, Chao Wu, Yan Xiao, Lulu Zhang, Lianlian Han, Shengyuan Dang, Yan Xu, Qi-Wen Yang, Sheng-Yong Xu, Hua-Dong Zhu, Ying-Chun … [cited by applicant]
Sabino-Silva, R., Jardim, A. C. G., & Siqueira, W. L. . “Coronavirus covid-19 impacts to dentistry and potential salivary diagnosis. .” Journal Article. (Feb. 2020) 1619-1621. 24. 4. Clinical Oral Investigations. [cited by applicant]
Huan Ma, Weihong Zeng, Hongliang He, Dan Zhao, Yunru Yang, Dehua Jiang, Peigen Yingjie Qi, Weihuang He, Changcheng Zhao, Ruting Yi, Xiaofang Wang, Bo Wang, Yuanhong Yun Yang, Arnaud John Kombe Kombe, Chengchao Ding, Jia… [cited by applicant]
Jeanethe A. Anguizola, Erika L. Pfaunmiller, Mitchell L. Milanuk, David S. Hage, Peak decay analysis and biointeraction studies of immunoglobulin binding and dissociation on protein G affinity microcolumns, Methods, vol… [cited by applicant]
Yoo MJ, Schiel JE, Hage DS. Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding. J Chromatogr B Analyt Technol Biomed Life Sci. Jun. 15, 2010;878(20):1707-13. do… [cited by applicant]
Anguizola J, Joseph KS, Barnaby OS, Matsuda R, Alvarado G, Clarke W, Cerny RL, Hage DS. Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs … [cited by applicant]
COVID-19 detected in saliva of infected patients. (2020). Retrieved Mar. 27, 2020, from https://w-vvw.healio.com!infectious-disease/emerging-diseases/news/online/%7B7d347043-f342-4 7 4 f-8cd6-60ecf6372c 13% 7D/covid-19-… [cited by applicant]